Target intelligence / Profile preview

NUS1 pseudogene 1 (NUS1P1)

Target: NUS1P1
Molecular classification: Other (Pseudogene)

Overview

NUS1 pseudogene 1 (NUS1P1) is a non-coding pseudogene related to the functional NUS1 gene, which encodes the Nogo-B receptor (NgBR), a protein involved in dolichol synthesis, cholesterol trafficking, and glycosylation. Pseudogenes like NUS1P1 are DNA sequences similar to known genes but typically lack the capability to encode functional proteins due to mutations or deletions. While the protein-coding NUS1 gene is of significant biomedical interest, NUS1P1 itself is not directly involved in biological processes or considered a druggable target.

Other names: NUS1P1NUS1 pseudogene 1

Mechanism of action

None applicable (pseudogene)

Biological functions

None (Pseudogene; does not encode a functional protein)

Disease associations

None. There are no known disease roles associated directly with NUS1P1 as a pseudogene. Published literature and databases associate disease phenotypes only with the protein-coding NUS1 gene.

Safety considerations

None. As a pseudogene, NUS1P1 is not a therapeutic target and does not present known safety concerns or therapeutic challenges.

Interacting drugs

None. Drugs do not target NUS1P1, as it is not a functional protein-coding gene.

Biomarkers

None reported; not used for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on NUS1 pseudogene 1 (NUS1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NUS1 pseudogene 1 (NUS1P1).

Explore the full profile